Stifel Maintains Buy on Clarivate, Lowers Price Target to $5

Benzinga Newsdesk www.benzinga.com Negative 58.3%

Neg 58.3% Neu 0% Pos 0%

Stifel analyst Shlomo Rosenbaum maintains Clarivate (NYSE:CLVT) with a Buy and lowers the price target from $6 to $5.

Comments

No comments yet. Be the first!